Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Adagio Medical Holdings (ADGM) Asset Writedowns and Impairment (2023 - 2024)

Adagio Medical Holdings has reported Asset Writedowns and Impairment over the past 2 years, most recently at -$15000.0 for Q3 2024.

Quarterly Asset Writedowns and Impairment changed N/A to -$15000.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $30000.0 through Sep 2024, changed N/A year-over-year, with the annual reading at $18.9 million for FY2024, 75412.0% up from the prior year.
Asset Writedowns and Impairment was -$15000.0 for Q3 2024 at Adagio Medical Holdings, up from -$41000.0 in the prior quarter.
Over five years, Asset Writedowns and Impairment peaked at $82000.0 in Q1 2024 and troughed at -$41000.0 in Q2 2024.